Join the club for FREE to access the whole archive and other member benefits.

Synchron helps paralysed patients control digital devices with thoughts alone


Key points from article :

Synchron has been cleared by the FDA to begin a clinical trial with human participants.

The COMMAND trial will take place later this year in New York and will include six patients with severe paralysis.

Device is implanted into the motor cortex of the brain through the jugular vein.

A minimally invasive procedure that takes about two hours.

Translates brain activity to allow users complete tasks on external devices (texting, emailing, online shopping and accessing telemedicine).

Synchron has begun studying the effects among paralysis patients in Australia.

Showed that the participants could type on their devices with only their thoughts.

Data from the first two patients in the study were published in the Journal of NeuroInterventional Surgery.

Scored $40 million in Series B funding for its implantable brain-computer interface tech.

“Synchron’s north star is to achieve whole-brain data transfer,” - Thomas Oxley, CEO of Synchron.

Implantable brain computer interface received FDA approval for human trials in US

Mentioned in this article:

Click on resource name for more details.

Journal of NeuroInterventional Surgery

Peer review journal for scientific research to the field of neurointerventional surgery


Brain computer interface company

Thomas Oxley

CEO of Synchron, Co-head Vascular Bionics laboratory at the University of Melbourne